Resverlogix
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4820 Richard Rd SW 300, Calgary, Alberta...Phone Number
(403) 254-9252Website
www.resverlogix.comRevenue
$6 MillionStock Symbol
RVXIndustry
About Resverlogix
Founded in 2001, Resverlogix operates as a late-stage clinical biotechnology company. The company is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular, end-stage renal, chronic kidney, neurodegenerative, fabry, peripheral artery, and other orphan diseases, as well as diabetes mellitus. The company is headquartered in Calgary, Alberta, Canada.Explore more
Resverlogix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Resverlogix
Compare insights from companies similar to Resverlogix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Resverlogix Tech Stack
A closer look at the technologies used by Resverlogix
Top Business Services Companies
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Resverlogix
Sign Up For FreeTo access detailed company insights
Founded in 2001, Resverlogix operates as a late-stage clinical biotechnology company. The company is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular, end-stage renal, chronic kidney, neurodegenerative, fabry, peripheral artery,... Read More
